israel diabetes market size (2)

According to Renub Research latest report “North America Kidney Transplant Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth” North America Kidney Transplant Market is estimated to reach US$ 14.76 Billion by 2027. In recent times, the growth in demand for novel tissue transplantation products and organ transplantation for treatment of organ failure has increased immensely. As per the United Network for Organ Sharing (UNOS) organisation, there were 35,446 organ transplants that took place in 2022 (January-October), in North America. The North American public has the availability of advanced technologically advanced equipment’s, and the increasing expenditure in healthcare sector by the government.

A kidney transplant is a procedure where a healthy kidney is transferred from one person into the body of other person, whose kidneys no longer function properly. This loss of function of the kidney, is known as end-stage chronic kidney disease (ESRD). It is the most common reas

According to Renub Research’s latest report, “Israel Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis” the Israel Diabetes Market is estimated to reach US$ 3.22 Billion by 2028. In Israel, Diabetes is a leading cause of death. Diabetes is a long-term disease that rises when blood sugar is too high. The rising population, lack of physical activities, family background, increased awareness among people regarding medical treatment options, and unhealthy meals drive the market. However, the high costs of medicine and lack of reimbursement hinder the market. According to WHO data published in 2020, Diabetes Mellitus Deaths in Israel reached 1,913 total deaths.

The increasing population in Israel creates a primary Type-2 Diabetes disease. Israel Type 2 diabetes is considered an epidemic and continues rising. In Israel, the percentage of diabetes in the Arab population is twice that in the Jewish people. Also, Insulin dependent